Anne G. Osborn, Luke L. Linscott, Karen L. Salzman: Osborn’s Brain: Imaging, Pathology and Anatomy, 3rd Edition Luigi Mansi Book Review 11 January 2024 Pages: 1497 - 1497
Guardians of precision: advancing radiation protection, safety, and quality systems in nuclear medicine Francesco GiammarilePeter KnollRoberto C. Delgado Bolton Review Article Open access 06 February 2024 Pages: 1498 - 1505
MIDOS: a novel stochastic model towards a treatment planning system for microsphere dosimetry in liver tumors Carlos Huesa-BerralJulia D. WithrowAlejandro Bertolet Original Article 29 December 2023 Pages: 1506 - 1515
Deep transformer-based personalized dosimetry from SPECT/CT images: a hybrid approach for [177Lu]Lu-DOTATATE radiopharmaceutical therapy Zahra MansouriYazdan SalimiHabib Zaidi Original Article Open access 25 January 2024 Pages: 1516 - 1529
Platelet-derived growth factor receptor β-targeted positron emission tomography imaging for the noninvasive monitoring of liver fibrosis Zhao LiHao YangXiaofeng Lu Original Article 08 January 2024 Pages: 1530 - 1543
Peptidic heterodimer-based radiotracer targeting fibroblast activation protein and integrin αvβ3 Kehuang LiuTao JiangShuo Hu Original Article 26 January 2024 Pages: 1544 - 1557
Brachytherapy at the nanoscale with protein functionalized and intrinsically radiolabeled [169Yb]Yb2O3 nanoseeds Sanchita GhoshSourav PatraRubel Chakravarty Original Article 25 January 2024 Pages: 1558 - 1573
Challenges coexist with opportunities: development of a macrocyclic peptide PET radioligand for PD-L1 Wenpeng HuangMai Hong SonWeibo Cai Editorial 16 March 2024 Pages: 1574 - 1577
PET imaging of PD-L1 with a small molecule radiotracer Yajie ZhaoJessica C. HsuWeibo Cai Editorial 09 March 2024 Pages: 1578 - 1581
Development of small-molecular-based radiotracers for PET imaging of PD-L1 expression and guiding the PD-L1 therapeutics Hongzhang YangXinying ZengZhide Guo Original Article 22 January 2024 Pages: 1582 - 1592
A rationally designed nuclei-targeting FAPI 04-based molecular probe with enhanced tumor uptake for PET/CT and fluorescence imaging Xingyang ZhaoGuojin ZhangLiming Nie Original Article 21 March 2024 Pages: 1593 - 1604
Initial results with [18F]FAPI-74 PET/CT in idiopathic pulmonary fibrosis Yuriko MoriVasko KramerÁlvaro Undurraga Short Communication Open access 20 December 2023 Pages: 1605 - 1611
Impact on cardiovascular outcome of coronary revascularization-induced changes in ischemic perfusion defect and myocardial flow reserve Roberta AssanteEmilia ZampellaWanda Acampa Original Article Open access 09 January 2024 Pages: 1612 - 1621
Downward myocardial creep during stress PET imaging is inversely associated with mortality Keiichiro KuronumaRobert J.H. MillerPiotr J. Slomka Original Article Open access 23 January 2024 Pages: 1622 - 1631
Quantitative analysis of myocardial blood flow in surgically revascularized and not revascularized myocardial segments. A pilot PET study M. GrandinettiG. LocorotondoM. Massetti Short Communication 18 December 2023 Pages: 1632 - 1638
A comparison of visual assessment and semi-quantification for the diagnostic and prognostic use of [18F]flortaucipir PET in a memory clinic cohort Gregory MathouxCecilia BoccaliniValentina Garibotto Original Article Open access 06 January 2024 Pages: 1639 - 1650
[18F]SynVesT-1 and [18F]FDG quantitative PET imaging in the presurgical evaluation of MRI-negative children with focal cortical dysplasia type II Ling XiaoJinhui YangShuo Hu Original Article 06 January 2024 Pages: 1651 - 1661
The spatial extent of tauopathy on [18F]MK-6240 tau PET shows stronger association with cognitive performances than the standard uptake value ratio in Alzheimer’s disease Thomas GérardLise ColmantBernard Hanseeuw Original Article Open access 17 January 2024 Pages: 1662 - 1674
Thyrotoxicosis is no insurance against thyroid cancer Sabina DizdarevicV. Ralph McCreadyMirza Skalonja Editorial 04 January 2024 Pages: 1675 - 1677
The European Association of Nuclear Medicine (EANM)’s Response to the 2023 European Thyroid Association (ETA) clinical practice guidelines for thyroid nodule management and nuclear medicine: a deliberate oversight? Michael C. KreisslPetra Petranović OvčaričekLuca Giovanella Editorial Open access 16 January 2024 Pages: 1678 - 1681
On the rational use of thyroid scintigraphy in thyrotoxic patients in the age of integrated diagnostics Alfredo CampennìPetra Petranović OvčaričekLuca Giovanella Editorial 03 February 2024 Pages: 1682 - 1684
A comparison of [18F]AlF- and 68Ga-labeled dual targeting heterodimer FAPI-RGD in malignant tumor: preclinical evaluation and pilot clinical PET/CT imaging Nan LiuQiang WanWei Zhang Original Article 22 January 2024 Pages: 1685 - 1697
Amino acid PET vs. RANO MRI for prediction of overall survival in patients with recurrent high grade glioma under bevacizumab therapy Artem ChabanBirgit WaschulzikIgor Yakushev Short Communication Open access 17 January 2024 Pages: 1698 - 1702
A bis-boron boramino acid PET tracer for brain tumor diagnosis Zhu LiJunyi ChenZhibo Liu Original Article 09 January 2024 Pages: 1703 - 1712
First-in-human validation of enzymolysis clearance strategy for decreasing renal radioactivity using modified [68Ga]Ga-HER2 Affibody Mingru ZhangFei KangJing Wang Original Article 13 January 2024 Pages: 1713 - 1724
More than meets the eye: 2-[18F]FDG PET-based radiomics predicts lymph node metastasis in colorectal cancer patients to enable precision medicine Wenpeng HuangMai Hong SonWeibo Cai Editorial 01 March 2024 Pages: 1725 - 1728
2-[18F]FDG PET-based quantification of lymph node metabolic heterogeneity for predicting lymph node metastasis in patients with colorectal cancer Lian XuGan HuangRuohua Chen Original Article 27 December 2023 Pages: 1729 - 1740
The accuracy and intra- and interobserver variability of PSMA PET/CT for the local staging of primary prostate cancer Maarten L. DonswijkRosemarijn H. EttemaDaniela E. Oprea-Lager Original Article Open access 26 January 2024 Pages: 1741 - 1752
First-in-human study of PSMA-targeting agent, [18F]AlF-P16-093: dosimetry and initial evaluation in prostate cancer patients Ruiyue ZhaoMiao KeXinlu Wang Original Article 12 January 2024 Pages: 1753 - 1762
Combination of [18F]FDG and [18F]PSMA-1007 PET/CT predicts tumour aggressiveness at staging and biochemical failure postoperatively in patients with prostate cancer Jisu KimSeunghwan LeeMijin Yun Original Article 11 January 2024 Pages: 1763 - 1772
Surgical evidence-based comparison of [68Ga]Ga-FAPI-04 PET and MRI-DWI for assisting debulking surgery in ovarian cancer patients Xiang LiXiaohui LvJing Wang Original Article 10 January 2024 Pages: 1773 - 1785
[68 Ga]Ga-FAPI-46 PET/CT for locoregional lymph node staging in urothelial carcinoma of the bladder prior to cystectomy: initial experiences from a pilot analysis Lena M. UnterrainerLennert EismannGerald B. Schulz Short Communication Open access 18 January 2024 Pages: 1786 - 1789
False-positive [18F]FAPI-74 uptake caused by blood retention due to external jugular vein thrombus: Pitfall in the early-phase scan Akihito OhnishiTomohiko YamaneHisateru Yasui Image of the Month 11 January 2024 Pages: 1790 - 1791
[18F]F-AlF-NOTA-octreotide PET/CT detected the [18F]FDG negative ectopic ACTH tumor in mediastinum Lin ChenYing ZhangHong Zhang Image of the Month 18 January 2024 Pages: 1792 - 1793
Neuronal intranuclear inclusion disease with cerebellar white matter tau uptake and incidental meningioma Yan ZhangMei XinChenpeng Zhang Image of the Month 26 January 2024 Pages: 1794 - 1795
Correction to: A bis-boron boramino acid PET tracer for brain tumor diagnosis Zhu LiJunyi ChenZhibo Liu Correction 22 March 2024 Pages: 1796 - 1797
Correction to: Positron emission tomography in the diagnosis and follow-up of transthyretin amyloid cardiomyopathy patients: A systematic review H. S. A. TingenA. TubbenR. H J. A. Slart Correction Open access 22 August 2023 Pages: 1798 - 1798
